LONDON, UK - October 22, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Tristel plc (AIM: TSTL) and is pleased to announce the placement of Anna Wasyl as Chief Financial Officer (CFO).Tristel plc is a global infection prevention company focused on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry.Anna Wasyl is a seasoned CFO with 20+ years of experience in multinational organizations, specializing in…
In the third quarter of 2025 Coulter Partners drove global executive search for a wide range of life sciences, health, and technology organizations.We successfully placed executives for independent and VC & PE-backed firms, alongside large-cap and mid-cap public companies, filling critical roles across diverse disciplines worldwide. CEO/ C-suite/ BoardCEO, Diagnostic & laboratory services (PE-backed), FranceCEO, Small-molecule therapies (VC-backed), ItalyCEO, Bio-storage solutions (PE-backed), UKCEO, Cell & gene therapies (VC-backed), DenmarkChief Financial Officer, Medical…
BioBeat is joining the One Nucleus hub for life science innovation
Cambridge, UK: 23 October 2025
The exciting new chapter for BioBeat begins with One Nucleus! BioBeat, connecting entrepreneurs with biotech leaders, is joining the One Nucleus hub for life science innovation. One Nucleus supports companies of all sizes through networking, training and thought leadership.
For the past twelve years, BioBeat has energised the UK life sciences scene through delivering an informed conversational forum for ideas exchange, challenging norms and future scoping among leaders in the…
Creative Biolabs has developed a multi-layered model system and offers the global community preclinical research tools that better mimic human physiological characteristics.In vivo disease models bridge the gap between the fundamental science and the drug candidate validation. The rodent models have long been used to understand the cancer mechanisms, immune system responses, and drug action pathways, and model relevance is being enhanced by genetic engineering and humanization technologies."Successful drug discovery increasingly depends on the biological relevance of the models," said the…
Combines single-organ, multi-organ, and higher-throughput configurations within one scalable platform
Fully compatible with existing PhysioMimix accessories, validated protocols, consumables, and organ model kits for seamless workflow integration
Cambridge, UK, 14 October 2025: CN Bio, a leading provider of benchtop Organ-on-a-chip (OOC) solutions that accelerate drug discovery and development, today announced the launch of PhysioMimix® Core. Combining the capabilities of CN Bio’s existing suite of instruments, PhysioMimix Core is the first OOC solution to deliver validated performance…
Amsbio has launched over a range of over 30 independently developed and manufactured organoid culture-related cytokines for researchers working with stem cells and induced pluripotent stem cells (iPSCs). This new range of cytokines is tailored for and validated in organoid culture, ensuring high compatibility and making your research more controlled and reproducible.
In a growing number of research areas, organoids have become a key cell culture tool, widely applied in development and disease modelling, precision medicine, toxicology studies, and regenerative medicine.…
LONDON, October 14, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Proveca Ltd (“Proveca”) and is pleased to announce the placement of Gregory Reinaud as Chief Operating Officer (COO).Proveca is a specialist pharmaceutical company dedicated to providing licensed medicines for children. The Company develops and licenses medicines for children with long-term, chronic conditions, addressing the significant issue of children being prescribed adult…
On Wednesday, 15 October, One Nucleus is partnering with Longfellow to host the very first Elevate event at the newly completed Cam3 building on the CamLIFE campus in Cambridge.
Titled Breakfast and Brilliance, the morning will offer just that: a delicious breakfast, opportunities to connect with fellow life science professionals, and an inspiring keynote from Brendan Hall.
Brendan skippered a racing yacht in the legendary Clipper Round the World Yacht Race—a 35,000-mile circumnavigation with amateur crews competing in identical boats. Though he was the youngest and least experienced skipper…
Sandwich, UK - 11 October 2025: A new science specialist sixth form is set to open next year, based at Sandwich science and innovation campus, Discovery Park.
The new sixth form is named Carbon 6 Academy of Science, ideal for ambitious students aged 16-18 with a passion for science and maths. The academy is designed for those looking to pursue a STEM career, setting students up for success with routes into further education including degree apprenticeships and university study.
The unique location within a world-class science park gives students access to state-of-the-art professional…
After 23 years in business, Spinning Clock Limited is turning the page with a bold new brand identity and new headquarters. Now known simply as CLOK, the company has rebranded to reflect their values of precision, clarity and creativity – and has relocated from Nottingham to a newly converted commercial barn nestled between Center Parcs and Sherwood Pines.
Founded in 2002, the company has grown from its roots as a creative agency into a trusted partner for its client's seeking clarity, precision, and results. CLOK is proudly the same limited company that was formed 23 years ago in 2002 and…